Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Stiplastics has a patent portfolio focused on the Medical Devices & Mechanical Engineering technology area. The portfolio currently contains 1 pending office action. This single action is being processed within 1 distinct art unit, reflecting a specific scope of current patent office activity for the company. This approach suggests that Stiplastics is prioritizing a particular mechanical or medical innovation in its current filing strategy.
The prosecution is handled by 1 distinct examiner, ELLABIB, MAAP AHMED. As the busiest examiner, ELLABIB, MAAP AHMED is responsible for 1 busiest examiner pending office action. The presence of only 1 distinct examiner indicates that all active prosecution for Stiplastics is currently under the review of one individual. For the practitioner, this means that the prosecution strategy should be informed by the prior actions and preferences of ELLABIB, MAAP AHMED. The lack of examiner and art unit diversity simplifies the management of the portfolio but also means that current intellectual property goals are dependent on the outcomes generated by this single examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ELLABIB, MAAP AHMED | 1 | 64.0% | +37.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17422663 | INHALATION CHAMBER | ELLABIB, MAAP AHMED | — |
| Art Unit | Apps |
|---|---|
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17422663 | INHALATION CHAMBER | ELLABIB, MAAP AHMED | 3785 | §103 | Final Rejection | — | Pending | Jul 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialStiplastics has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Maap Ahmed Ellabib has the most, with 1 of Stiplastics's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
